PROCEPT BioRobotics (PRCT) Cash from Operations (QoQ) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | PROCEPT BioRobotics | 1.22 Bn | 940.44 Mn | 62.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.51% |
| Mar 31, 2026 | -269.20% |
| Dec 31, 2025 | -55.64% |
| Sep 30, 2025 | 55.89% |
| Jun 30, 2025 | 11.41% |
| Mar 31, 2025 | 47.58% |
| Dec 31, 2024 | -72.29% |
| Sep 30, 2024 | -19.47% |
| Jun 30, 2024 | 51.26% |
| Mar 31, 2024 | -30.22% |
| Dec 31, 2023 | -30.88% |
| Sep 30, 2023 | 33.16% |
| Jun 30, 2023 | 21.12% |
| Mar 31, 2023 | -42.72% |
| Dec 31, 2022 | -26.81% |
| Sep 30, 2022 | -15.91% |
| Jun 30, 2022 | 6.06% |
| Mar 31, 2022 | -10.65% |
| Dec 31, 2021 | -29.21% |
| Sep 30, 2021 | 1.22% |